Related Experiment Video
Updated: May 26, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
[A Case of Primary Breast Diffuse Large B-Cell Lymphoma in a Male Patient]
Hanae Matsuda1, Masae Miyashita, Kazuo Tanaka
1Dept. of Breast Surgery, Ishikiriseiki Hospital.
Insights
A 68-year-old man was diagnosed with primary breast diffuse large B-cell lymphoma (DLBCL). Treatment involved surgical resection followed by polatuzumab vedotin and R-CHP chemotherapy.
Area of Science:
- Oncology
- Hematology
- Medical Imaging
Background:
- Primary breast lymphoma is a rare condition.
- Diffuse large B-cell lymphoma (DLBCL) can manifest in the breast.
- Early diagnosis and appropriate treatment are crucial for patient outcomes.
Purpose of the Study:
- To report a case of primary breast DLBCL.
- To describe the diagnostic process including imaging and biopsy.
- To outline the treatment strategy including surgery and chemotherapy.
Main Methods:
- A 68-year-old male patient presented with a breast mass.
- Diagnostic workup included breast ultrasonography, core needle biopsy (CNB), positron emission tomography-computed tomography (PET-CT), and bone marrow examination.
- Treatment consisted of surgical resection followed by polatuzumab vedotin and R-CHP (Pola + R-CHP) chemotherapy.
Main Results:
- Ultrasonography showed an irregular hypoechoic mass.
- CNB confirmed diffuse large B-cell lymphoma (DLBCL).
- Staging investigations revealed no extranodal involvement, confirming primary breast DLBCL. The patient underwent surgery and chemotherapy.
Conclusions:
- Primary breast DLBCL is a rare but treatable malignancy.
- Multimodality treatment including surgery and chemotherapy (Pola + R-CHP) can be effective.
- This case highlights the importance of considering lymphoma in breast masses.
Abstract:
The patient was a 68-year-old man who presented with a progressively enlarging mass in the left breast. Breast ultrasonography revealed an irregular hypoechoic mass in region E of the left breast. A core needle biopsy (CNB) revealed diffuse large B-cell lymphoma (DLBCL). Positron emission tomography-computed tomography (PET-CT) showed no abnormal uptake in organs outside the breast, and bone marrow examination revealed no involvement. The patient was diagnosed with primary DLBCL in the breast. Surgical resection was chosen for both a definitive diagnosis and because the patient experienced pain due to the rapid enlargement of the tumor. Postoperatively, polatuzumab vedotin and R-CHP (Pola + R-CHP) were administered.
Related Concept Videos
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...